Dr. Michael A. Dorman, MD

Dr. Dorman practices at Midwest Center for Dermatology & Pathology in West Bloomfield, Michigan.

Dr. Dorman's NPI, 1841281532, was assigned on November 2, 2005. Dr. Dorman graduated from Vagelos College of Physicians and Surgeons in 1987. Dr. Dorman holds Michigan license 4301056439.

Dr. Dorman's primary practice is Midwest Center for Dermatology & Pathology, at 6330 Orchard Lake Rd, West Bloomfield, MI 48322 in Oakland County. The practice phone is (586) 286-0112.

Dr. Dorman's primary practice is Midwest Center for Dermatology & Pathology in West Bloomfield, Michigan. Dr. Dorman is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Midwest Dermatology. Dmand AI also links Dr. Dorman to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dorman practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Dorman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dorman is board certified in dermatology by the American Board of Dermatology. Dr. Dorman is licensed in Michigan.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Dorman treats.

CMS data shows 5,195 Medicare services from Dr. Dorman across 21 procedure codes in 2024, for 1,244 Medicare patients. Medicare paid $252,679 for them. Every service was in an office.

CMS counts 1,244 Medicare patients who saw Dr. Dorman in 2024. The largest group is 65 to 74, with 632 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dorman's median patient age at 65, with 48% women.

In 2024, Dr. Dorman wrote 2,925 Medicare Part D claims for 1,054 patients. 93% of them were for generic drugs. CMS names the drug for 2,753 of them, across 33 drugs with 11 or more claims each, at $455,350 in total drug cost. In 2023, CMS named 2,189 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Dorman for performance year 2024, reported as part of a group. Dr. Dorman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 899 procedures of skin biopsy by Dr. Dorman, more than 98% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 2,251 general payments to Dr. Dorman from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Galderma Laboratories, L.P. paid the most, $151,885.

Dmand AI lists 4 awards for Dr. Dorman, most recently CMS Stage 1 EHR in 2012.

Dr. Dorman graduated from Vagelos College of Physicians and Surgeons in 1987. Dr. Dorman is a member of AAD.

Dr. Dorman is in network with 19 carriers, including Aetna, Health Alliance Plan and Priority Health. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.